118 related articles for article (PubMed ID: 19679406)
1. Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.
Rosenthal DI; Fuller CD; Barker JL; Mason B; Garcia JA; Lewin JS; Holsinger FC; Stasney CR; Frank SJ; Schwartz DL; Morrison WH; Garden AS; Ang KK
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):455-61. PubMed ID: 19679406
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison between carotid-sparing IMRT and 3DCRT in early glottic cancer patients treated with definitive radiation therapy.
Kaur H; Thakur N; Sharma R; Sudan M; Jain N; Kaur S; Lehal P
J Cancer Res Ther; 2024 Jan; 20(1):327-332. PubMed ID: 38554342
[TBL] [Abstract][Full Text] [Related]
3. Carotid dosimetry for T1 glottic cancer radiotherapy.
Garcez K; Lim CC; Whitehurst P; Thomson D; Ho KF; Lowe M; Sykes A; Lee LW; Yap B; Slevin N
Br J Radiol; 2014 Jun; 87(1038):20130754. PubMed ID: 24628251
[TBL] [Abstract][Full Text] [Related]
4. Accelerated three-dimensional conformal radiotherapy for early-stage glottic cancer in reducing dose to the internal carotid artery and pharyngeal constrictor muscles.
Tomizawa K; Motegi A; Oyoshi H; Fujisawa T; Zenda S; Zhou Y; Nakamura M; Hirata H; Hojo H; Kageyama SI; Hirotaki K; Matsuura K; Akimoto T
Head Neck; 2024 Feb; 46(2):239-248. PubMed ID: 37933710
[TBL] [Abstract][Full Text] [Related]
5. Measurement and Incorporation of Laryngeal Motion Using cine-MRI on an MR-Linear Accelerator to Generate Radiation Therapy Plans for Early-stage Squamous Cell Cancers of the Glottis.
Gupta A; McQuaid D; Dunlop A; Barnes H; Mohajer J; Smith G; Nartey J; Morrison K; Herbert T; Alexander S; McNair H; Newbold K; Nutting C; Bhide S; Harrington KJ; Wong KH
Adv Radiat Oncol; 2024 Jun; 9(6):101490. PubMed ID: 38681895
[TBL] [Abstract][Full Text] [Related]
6. Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord.
Chera BS; Amdur RJ; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1380-5. PubMed ID: 19942356
[TBL] [Abstract][Full Text] [Related]
7. Carotid sparing hypofractionated tomotherapy in early glottic cancers: Refining image guided IMRT to improve morbidity.
Chatterjee S; Guha S; Prasath S; Mallick I; Achari R
J Cancer Res Ther; 2013; 9(3):452-5. PubMed ID: 24125982
[TBL] [Abstract][Full Text] [Related]
8. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
Zumsteg ZS; Riaz N; Jaffery S; Hu M; Gelblum D; Zhou Y; Mychalczak B; Zelefsky MJ; Wolden S; Rao S; Lee NY
Oral Oncol; 2015 Jul; 51(7):716-23. PubMed ID: 25958831
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy for early glottic cancer: transition to a new standard of care?
Samuels MA; Freedman LM; Elsayyad N
Future Oncol; 2016 Nov; 12(22):2615-2630. PubMed ID: 27502431
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
11. Can carotid-sparing radiotherapy approaches replace with conventional techniques for the patients with T1 glottic larynx cancer?
Sert F; Karakoyun-Çelik O; Esassolak MA
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):267-74. PubMed ID: 22991987
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.
Kocher M; Soffietti R; Abacioglu U; Villà S; Fauchon F; Baumert BG; Fariselli L; Tzuk-Shina T; Kortmann RD; Carrie C; Ben Hassel M; Kouri M; Valeinis E; van den Berge D; Collette S; Collette L; Mueller RP
J Clin Oncol; 2011 Jan; 29(2):134-41. PubMed ID: 21041710
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.
Mohamed ASR; Smith BD; Smith JB; Sevak P; Malek JS; Kanwar A; Browne T; Gunn GB; Garden AS; Frank SJ; Morrison WH; Phan J; Zafereo M; Skinner H; Lai SY; Hutcheson KA; Lewin JS; Hessel AE; Thekdi AA; Weber RS; Fuller CD; Rosenthal DI
Laryngoscope; 2020 Jan; 130(1):146-153. PubMed ID: 30756394
[TBL] [Abstract][Full Text] [Related]
14. Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.
Gujral DM; Long M; Roe JW; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):42-50. PubMed ID: 27815039
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy for stage I glottic cancer: a short-term outcomes compared with three-dimensional conformal radiotherapy.
Cho IJ; Chung WK; Lee JK; Lee MC; Paek J; Kim YH; Jeong JU; Yoon MS; Song JY; Nam TK; Ahn SJ; Lee DH; Yoon TM; Lim SC
Radiat Oncol J; 2019 Dec; 37(4):271-278. PubMed ID: 31918465
[TBL] [Abstract][Full Text] [Related]
16. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
[TBL] [Abstract][Full Text] [Related]
17. Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study.
Dekura Y; Yasuda K; Minatogawa H; Uchinami Y; Tsushima N; Suzuki T; Kano S; Mori T; Nishioka K; Kobashi K; Katoh N; Homma A; Aoyama H
J Radiat Res; 2024 Jan; 65(1):63-70. PubMed ID: 37952082
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system.
Lourenção M; Arruda GV; Rocha LP; Galendi JSC; de Oliveira JC; Jacinto AA
BMC Health Serv Res; 2023 Jun; 23(1):592. PubMed ID: 37291564
[TBL] [Abstract][Full Text] [Related]
19. Early-Stage Glottic Squamous Cell Carcinoma in the Era of Image-Guided Radiotherapy.
Gupta A; Wong KH; Newbold K; Bhide S; Nutting C; Harrington KJ
Front Oncol; 2021; 11():753908. PubMed ID: 34616688
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
